• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测肝硬化患者一年再入院的生物标志物和社会人口学因素。

Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients.

作者信息

Dai Jingyi, Zhao Jun, Du Yingrong, McNeil Edward B, Chongsuvivatwong Virasakdi

机构信息

Department of Liver Diseases, The Third People's Hospital of Kunming City, Kunming, Yunnan, People's Republic of China.

Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

出版信息

Ther Clin Risk Manag. 2019 Aug 8;15:979-989. doi: 10.2147/TCRM.S203883. eCollection 2019.

DOI:10.2147/TCRM.S203883
PMID:31496713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6691191/
Abstract

BACKGROUND

Hospital readmissions of patients with cirrhosis is a current problem in China. This study aims to estimate the readmission rate at one year after discharge and to identify associated risk factors of hospital readmission.

METHODS

Between January 2012 and December 2015, 3,402 patients admitted with cirrhosis were included in the study. The primary outcome was one-year inpatient readmission. Principal components analysis was conducted on the laboratory test indicators to reduce the number of dimensions. Univariate and multivariate analyses were performed using clinical and demographic data to identify independent associated factors of readmission within one year. The odds ratio (OR) and 95% confidence interval were used to assess the strength of association for each factor.

RESULTS

Two dimensions, namely "liver function" and "renal function", were revealed. Patients with a longer length of stay in the index admission (OR: 1.03; 95% CI: 1.03-1.04) and a higher dimension score of liver function (OR: 1.09; 95% CI: 1.05-1.13) were more likely to be readmitted within one-year. Older patients had a significantly higher odds of one-year readmission than younger patients (OR: 1.61; 95% CI: 1.22-2.11), patients who were married had a higher odds than those who were single (OR: 1.62; 95% CI: 1.12-2.36), and patients with hepatitis C virus were more likely to be readmitted within one year than patients with hepatitis B virus (OR: 1.51; 95% CI: 1.19-1.91).

CONCLUSION

Biomarkers and sociodemographic factors can identify patients at high risk for readmission within one year. Our data indicates the need to emphasize proper liver care to older patients who have been hospitalized for a long time.

摘要

背景

肝硬化患者的医院再入院是中国当前面临的一个问题。本研究旨在估计出院后一年的再入院率,并确定医院再入院的相关危险因素。

方法

2012年1月至2015年12月期间,3402例肝硬化住院患者纳入本研究。主要结局是一年期住院再入院。对实验室检查指标进行主成分分析以减少维度数量。使用临床和人口统计学数据进行单因素和多因素分析,以确定一年内再入院的独立相关因素。比值比(OR)和95%置信区间用于评估各因素的关联强度。

结果

揭示了两个维度,即“肝功能”和“肾功能”。首次入院住院时间较长的患者(OR:1.03;95%CI:1.03 - 1.04)以及肝功能维度评分较高的患者(OR:1.09;95%CI:1.05 - 1.13)在一年内更有可能再次入院。老年患者一年期再入院的几率显著高于年轻患者(OR:1.61;95%CI:1.22 - 2.11),已婚患者的几率高于单身患者(OR:1.62;95%CI:1.12 - 2.36),丙型肝炎病毒患者一年内再次入院的可能性高于乙型肝炎病毒患者(OR:1.51;95%CI:1.19 - 1.91)。

结论

生物标志物和社会人口学因素可识别一年内再入院风险较高的患者。我们的数据表明需要对长期住院的老年患者强调适当的肝脏护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cad/6691191/a4c7e9501994/TCRM-15-979-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cad/6691191/a3807c3cee46/TCRM-15-979-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cad/6691191/b1378059878f/TCRM-15-979-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cad/6691191/a4c7e9501994/TCRM-15-979-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cad/6691191/a3807c3cee46/TCRM-15-979-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cad/6691191/b1378059878f/TCRM-15-979-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cad/6691191/a4c7e9501994/TCRM-15-979-g0003.jpg

相似文献

1
Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients.预测肝硬化患者一年再入院的生物标志物和社会人口学因素。
Ther Clin Risk Manag. 2019 Aug 8;15:979-989. doi: 10.2147/TCRM.S203883. eCollection 2019.
2
Inflammatory Bowel Disease: Predictors and Causes of Early and Late Hospital Readmissions.炎症性肠病:早晚期住院再入院的预测因素和原因。
Inflamm Bowel Dis. 2017 Oct;23(10):1832-1839. doi: 10.1097/MIB.0000000000001242.
3
Readmission to the Intensive Care Unit: Incidence, Risk Factors, Resource Use, and Outcomes. A Retrospective Cohort Study.再入院至重症监护病房:发生率、危险因素、资源利用和结局。一项回顾性队列研究。
Ann Am Thorac Soc. 2017 Aug;14(8):1312-1319. doi: 10.1513/AnnalsATS.201611-851OC.
4
Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.加利福尼亚州肝硬化患者的医院肝硬化容量和再入院情况。
Dig Dis Sci. 2018 Sep;63(9):2267-2274. doi: 10.1007/s10620-018-4964-0. Epub 2018 Feb 19.
5
Risk Factors for 30-Day Readmissions of Individuals with Decompensated Cirrhosis.失代偿期肝硬化患者30天再入院的危险因素
South Med J. 2015 Nov;108(11):682-7. doi: 10.14423/SMJ.0000000000000371.
6
Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease.晚期肝病住院患者 30 天再入院的发生率和预测因素。
Clin Gastroenterol Hepatol. 2011 Mar;9(3):254-9. doi: 10.1016/j.cgh.2010.10.035. Epub 2010 Nov 17.
7
Evaluating the predictive strength of the LACE index in identifying patients at high risk of hospital readmission following an inpatient episode: a retrospective cohort study.评估LACE指数在识别住院患者出院后再次入院高风险患者方面的预测强度:一项回顾性队列研究。
BMJ Open. 2017 Jul 13;7(7):e016921. doi: 10.1136/bmjopen-2017-016921.
8
Causes and correlates of 30 day and 180 day readmission following discharge from a Medicine for the Elderly Rehabilitation unit.老年医学康复病房出院后 30 天和 180 天再入院的原因及相关因素。
BMC Geriatr. 2018 Aug 28;18(1):197. doi: 10.1186/s12877-018-0883-3.
9
Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge.肝硬化患者出院后在同一家医院和不同医院的再入院情况比较。
Am J Gastroenterol. 2019 Mar;114(3):464-471. doi: 10.14309/ajg.0000000000000050.
10
Factors associated with unplanned hospital readmission among patients 65 years of age and older in a Medicare managed care plan.医疗保险管理式医疗计划中65岁及以上患者非计划再次入院的相关因素。
Am J Med. 1999 Jul;107(1):13-7. doi: 10.1016/s0002-9343(99)00159-x.

引用本文的文献

1
Hepatic encephalopathy and spontaneous bacterial peritonitis are associated with increased liver-related readmissions in cirrhosis.肝性脑病和自发性细菌性腹膜炎与肝硬化患者肝脏相关再入院率增加有关。
Front Med (Lausanne). 2025 Jan 31;12:1417222. doi: 10.3389/fmed.2025.1417222. eCollection 2025.
2
Hepatitis C Virus Infection and Hospital-Related Outcomes: A Systematic Review.丙型肝炎病毒感染与医院相关结局:系统评价。
Can J Gastroenterol Hepatol. 2024 Mar 7;2024:3325609. doi: 10.1155/2024/3325609. eCollection 2024.
3
Factors Associated With Repeat Emergency Department Visits for Low Back Pain.

本文引用的文献

1
Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China.使用直接作用抗病毒药物治愈丙型肝炎病毒:对中国的临床、经济、社会及患者价值
World J Hepatol. 2019 May 27;11(5):421-441. doi: 10.4254/wjh.v11.i5.421.
2
Incidence and cost analysis of hospital admission and 30-day readmission among patients with cirrhosis.肝硬化患者住院及30天再入院的发病率和成本分析。
Hepatol Commun. 2018 Jan 18;2(2):188-198. doi: 10.1002/hep4.1137. eCollection 2018 Feb.
3
Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study.
与腰痛患者再次前往急诊科就诊相关的因素。
Cureus. 2022 Feb 4;14(2):e21906. doi: 10.7759/cureus.21906. eCollection 2022 Feb.
肝硬化患者的住院再入院率及其原因:一项多州基于人群的队列研究。
Clin Gastroenterol Hepatol. 2016 Aug;14(8):1181-1188.e2. doi: 10.1016/j.cgh.2016.04.009. Epub 2016 Apr 13.
4
Readmission in Cirrhosis: a Growing Problem.肝硬化再入院:一个日益严重的问题。
Curr Treat Options Gastroenterol. 2016 Jun;14(2):236-46. doi: 10.1007/s11938-016-0091-1.
5
Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.乙型肝炎病毒和丙型肝炎病毒在肝内胆管癌中发挥不同的预后作用:一项荟萃分析。
World J Gastroenterol. 2016 Mar 14;22(10):3038-51. doi: 10.3748/wjg.v22.i10.3038.
6
The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis.在北美一个大型肝硬化患者队列中,3个月再入院率仍然高得令人无法接受。
Hepatology. 2016 Jul;64(1):200-8. doi: 10.1002/hep.28414. Epub 2016 Feb 19.
7
Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013.1990-2013 年中国 240 种疾病的特定病因死亡率:2013 年全球疾病负担研究的国家间系统分析。
Lancet. 2016 Jan 16;387(10015):251-72. doi: 10.1016/S0140-6736(15)00551-6. Epub 2015 Oct 26.
8
Antiviral therapy for chronic hepatitis B in China.中国慢性乙型肝炎的抗病毒治疗
Med Microbiol Immunol. 2015 Feb;204(1):115-20. doi: 10.1007/s00430-014-0380-z. Epub 2014 Dec 25.
9
Testosterone in men with advanced liver disease: abnormalities and implications.晚期肝病男性患者的睾酮:异常情况及影响
J Gastroenterol Hepatol. 2015 Feb;30(2):244-51. doi: 10.1111/jgh.12695.
10
Variation in the risk of readmission among hospitals: the relative contribution of patient, hospital and inpatient provider characteristics.医院再入院风险的差异:患者、医院及住院医疗服务提供者特征的相对作用。
J Gen Intern Med. 2014 Apr;29(4):572-8. doi: 10.1007/s11606-013-2723-7.